Emmaus Life Sciences, Inc.
EMMA
$0.07
$0.019.23%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 6.32M | 1.98M | 3.85M | 3.38M | 2.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 6.32M | 1.98M | 3.85M | 3.38M | 2.82M |
| Cost of Revenue | 344.00K | 168.00K | 235.00K | 247.00K | 150.00K |
| Gross Profit | 5.97M | 1.81M | 3.62M | 3.13M | 2.67M |
| SG&A Expenses | 2.07M | 2.60M | 3.18M | 1.90M | 2.98M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.53M | 2.81M | 3.45M | 2.20M | 3.19M |
| Operating Income | 3.79M | -823.00K | 402.50K | 1.18M | -370.00K |
| Income Before Tax | 1.34M | -3.33M | -1.94M | -1.50M | -1.73M |
| Income Tax Expenses | -1.00K | 4.00K | 16.00K | 579.00K | -590.00K |
| Earnings from Continuing Operations | 1.34M | -3.34M | -1.95M | -2.08M | -1.14M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1.34M | -3.34M | -1.95M | -2.08M | -1.14M |
| EBIT | 3.79M | -823.00K | 402.50K | 1.18M | -370.00K |
| EBITDA | 3.81M | -808.00K | 417.50K | 1.19M | -366.00K |
| EPS Basic | 0.02 | -0.05 | -0.03 | -0.03 | -0.02 |
| Normalized Basic EPS | 0.02 | -0.03 | -0.03 | -0.01 | -0.02 |
| EPS Diluted | 0.02 | -0.05 | -0.03 | -0.03 | -0.02 |
| Normalized Diluted EPS | 0.01 | -0.03 | -0.03 | -0.01 | -0.02 |
| Average Basic Shares Outstanding | 70.19M | 70.19M | 64.56M | 63.87M | 63.87M |
| Average Diluted Shares Outstanding | 120.54M | 70.19M | 64.56M | 63.87M | 63.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |